Dementia

  • Charles J. Golden
  • Antonia Chronopolous
Part of the The Springer Series in Adult Development and Aging book series (SSAD)

Abstract

Dementias were first recognized as a diagnostic issue during the 1800s and have become a major topic only within the last half century. As the population has aged, concern over the dementias has increased because of their higher incidence and the increased sensitivity in medical and mental health circles in recognizing the symptoms of these disorders. Kraepelin (1896) saw dementia as a disease of aging; later versions of his work recognized the writings of Alzheimer (1898) and others who identified the presence of presenile dementias. Over time, there has been increased attention to multiple etiologies and alternative methods of presentation.

Keywords

Vascular Dementia Alzheimer Type Memory Problem Normal Pressure Hydrocephalus Psychological Medicine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alafuzoff, I. (1992). The pathology of dementias: An overview. Ada Neurologica Scandinavica, 139 8–15.CrossRefGoogle Scholar
  2. Alafuzoff, I., Ronnberg, A., & Asikainen-Gustafsson, S. (1991). Clinical to histopathological correlation of the diagnosis of dementia. International Psychogeriatrics, 3 69–74.Google Scholar
  3. Altman, H., & Normile, H. (1988). What is the nature of the role of the serotonergic nervous system in learning and memory: Prospects for the development of a treatment strategy for senile dementia. Neurobiology of Aging, 9 627–639.PubMedCrossRefGoogle Scholar
  4. Alzheimer, A. (1898). Neuere Arbeiten uber die Dementia senilis und die auf atherimatoser Gefasserk rankung basierended Gehirnkrankheiten. Monatsschrift fuer Psychiatrie und Neurologie, 3 101–115.CrossRefGoogle Scholar
  5. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: Author.Google Scholar
  6. Anthony, J., LeResche, L., Niaz, U., von Korff, M., & Folstein, M. (1982). Limits of the mini-mental state as a screening test for dementia and delirium among hospital patients. Psychological Medicine, 12 397–408.PubMedCrossRefGoogle Scholar
  7. Artola, A., & Singer, W. (1987). Long term potentiation and NMDS receptors in rat visual cortex. Nature, 330 649–652.PubMedCrossRefGoogle Scholar
  8. Ashford, J. W., Kumar, V., Barringer, M., Becker, M., Bice, J., Ryan, N., & Vicari, S. (1992). Assessing Alzheimer severity with a global clinical scale. International Psychogeriatrics, 1 55–74.CrossRefGoogle Scholar
  9. Ball, M. (1980). Features of Creutzfeldt-Jakob disease in brains of patients with familial dementia of the Alzheimer’s type. Canadian Journal of Neurological Sciences, 7 51–57.PubMedGoogle Scholar
  10. Banfi, S., & Dorigotti, L. (1986). Experimental behavioral studies with oxiracetam on different types of chronic cerebral impairment. Clinical Neuropharmacology 9, 519–526.Google Scholar
  11. Beck, E., & Daniel, P. (1987). Neuropathology of transmissible spongiform encephalopathies. In S. Pruisner & M. McKinley (Eds.), Prions: Novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. San Diego: Academic.Google Scholar
  12. Berg, R., Franzen, M., & Wedding, D. (1994). Screening for brain impairment. New York: Springer.Google Scholar
  13. Berman, M. (1990). Severe brain dysfunction: Alcoholic Korsakoff’s syndrome. Alcohol Health and Research, 14 120–129.Google Scholar
  14. Biggins, C. A., Boyd, J., Harrop, F., Madeley, P., Mindham, R., Randall, J., & Spokes, E. (1992). A controlled longitudinal study of dementia in Parkinson’s disease. Journal of Neurology, Neuro-surgery, and Psychiatry, 55 566–571.CrossRefGoogle Scholar
  15. Bliwise, D., Carroll, J., Lee, K., Nekich, J., & Dement, W. (1993). Sleep and “sundowning” in nursing home patients with dementia. Psychiatry Research, 48 277–292.PubMedCrossRefGoogle Scholar
  16. Bliwise, D. L. (1993). Sleep in normal aging and dementia. Sleep, 16 40–81.PubMedGoogle Scholar
  17. Bonte, F. J., Ross, E. D., Chehabi, H. H., & Devous, M. D. (1986). SPECT study of regional cerebral blood flow in Alzheimer’s disease. Journal of Computed Assisted Tomography, 10 579–583.CrossRefGoogle Scholar
  18. Bottini, G., Vallar, G., Cappa, S., Monza, G. C., Scarpini, E., Baron, P., Cheldi, A., & Scarlato, G. (1992). Oxiracetam in dementia: A double blind, placebo-controlled study. Ada Neurologica Scandinavica, 86 237–241.CrossRefGoogle Scholar
  19. Brandt, J., & Butters, N. (1986). The alcoholic Wernicke-Korsakoff syndrome and its relationship to long term alcohol abuse. In G. Grant & K. Adams (Eds), Neuropsychological assessment of neuropsychiatric disorders. New York: Oxford University Press.Google Scholar
  20. Brenner, R., Ulrich, R., Spiker, D., Sclabassi, R., & Reynolds, C. (1986). Computerized EEG spectral analysis in elderly normal, demented, and depressed subjects. Eledroencephalography and Clinical Neurophysiology, 64 483–492.CrossRefGoogle Scholar
  21. Breslau, J., Starr, A., Sicotte, N., Higa, J., & Buchsbaum, M. (1989). Topographic EEG changes with normal aging and SDAT. Eledroencephalography and Clinical Neurophysiology, 40 281–289.CrossRefGoogle Scholar
  22. Brown, P. (1989). Central nervous system amyloidoses: A comparison of Alzheimer’s disease and Creutzfeldt-Jakob disease. Neurology, 39 1103–1105.PubMedCrossRefGoogle Scholar
  23. Burns, A., Philpot, M. P., Costa, D. C., Ell, P. J., & Levy, R. (1989). The investigation of Alzheimer’s disease with single photon emission tomography. Journal of Neurology, Neurosurgery and Psychiatry, 52 248–253.CrossRefGoogle Scholar
  24. Carlyle, W., Ancill, R., & Sheldon, L. (1993). Aggression in the demented patient: A double blind study of loxapine versus haloperidol. International Clinical Psychopharmacology, 8 103–108.PubMedCrossRefGoogle Scholar
  25. Chanarin, I., Deacon, R., Lumb, M., & Perry, J. (1989). Cobalaminfolate interrelationships. Blood Review, 3 211–215.CrossRefGoogle Scholar
  26. Copeland, J., Kelleher, N., Kellett, J., Gourlay, A., & Gurland, B. (1976). A semistructured clinical interview for the assessment of diagnosis and mental state in the elderly. Psychological Medicine, 6 439–449.PubMedCrossRefGoogle Scholar
  27. Copeland, J. R., Dewey, N., Henderson, A., Kay, D., & Neal, C. (1988). The Geriatric Mental State (GMS) used in the community: Replication studies of the computerized diagnoses AGECAT. Psych ological Medicine, 18 219–223.CrossRefGoogle Scholar
  28. Corey-Bloom, J., Galasko, D., Hofstetter, R., Jackson, J., & Thal, L. (1993). Clinical features distinguishing large cohorts with possible AD., probable AD., and mixed dementia. Journal of the American Geriatrics Society, 41 31–37.PubMedGoogle Scholar
  29. Cummings, J., & Benson, D. (1992). Dementia. Toronto: Butterwirth-Heinemann.Google Scholar
  30. Cutler, N. R., Fakouhi, D., Smith, W. T., Hendrie, H. C., Matsuo, F., Sramek, J. J., & Herting, R. L. (1993). Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer’s type. Journal of Geriatric Psychiatry and Neurology, 6 115–119.PubMedGoogle Scholar
  31. DeCarli, C., Haxby, J., Gillette, J., Teichberg, D., Rapoport, S., & Schapiro, M. (1992). Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology, 42 2029–2036.PubMedCrossRefGoogle Scholar
  32. Eberling, J. L., Jagust, W. J., Reed, B. R., & Baker, M. G. (1992). Reduced temporal lobe blood flow in Alzheimer’s disease. Neurobiology of Aging, 13 483–491.PubMedCrossRefGoogle Scholar
  33. Edwards, A. J. (1993). Dementia. New York: Plenum Press.CrossRefGoogle Scholar
  34. Evenhuis, H. M. (1992). Evaluation of a screening instrument for dementia in aging mentally retarded persons. Journal of Intellectual Disability Research, 36 337–347.PubMedCrossRefGoogle Scholar
  35. Fields, S., Fulop, G., Sachs, C., Strain, J., & Fillit, H. (1992). Usefulness of the neurobehavioral cognitive status examination in the hospitalized elderly. International Psychogeriatrics, 4 93–102.PubMedCrossRefGoogle Scholar
  36. Fischhof, P., Saletu, B., Ruther, E., Litschauer, G., Moslinger-Gehmayr, R., & Herrmann, W. (1992). Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID). Neuropsychobiology, 26 65–70.PubMedCrossRefGoogle Scholar
  37. Folstein, M., Folstein, S., & McHugh, P. (1975). “Mini-mental state”: A practical method for grading the cognitive states of patients for the clinician. Journal of Psychiatric Research, 12 189–198.PubMedCrossRefGoogle Scholar
  38. Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., & Winblad, B. (1992). Clinical diagnosis of Alzheimer’s disease and other dementias in a population survey. Archives of Neurology, 49 927–932.PubMedCrossRefGoogle Scholar
  39. Galasko, D., Klauber, M., Hofstetter, R., Salmon, D., Lasker, B., & Thal, L. (1990). The MMSE in the early diagnosis of Alzheimer’s disease. Archives of Neurology, 47 49–52.PubMedCrossRefGoogle Scholar
  40. Giurgea, C. (1972). Vers une pharmacologie de l’activité integrative du cerveau: Tentative du concept nootrope en psychopharmacologie. Actual Pharmacology, 25 115–156.Google Scholar
  41. Golden, C., Osmon, D., Moses, J., & Berg, R. (1981). Interpretation of the Halstead-Reitan Neuropsychological Battery. New York: Harcourt Brace Jovanovich.Google Scholar
  42. Golden, C., Zillmer, E., & Spiers, M. (1992). Neuropsychological assessment and intervention. Springfield, IL: Thomas.Google Scholar
  43. Goodwin, J. S., Goodwin, J. M., & Garry, P. J. (1983). Association between nutritional status and cognitive functioning in a healthy elderly population. Journal of the American Medical Association, 249 2917–2921.PubMedCrossRefGoogle Scholar
  44. Gottfries, C. (1991). Classifying organic mental disorders and dementia—A review of historical perspectives. International Psychogeriatrics, 3 9–17.Google Scholar
  45. Gottfries, C., Adolfsson, R., & Aquilonius, S. (1983). Biochemical changes in dementia disorders of the Alzheimer type (AD/SDAT). Neurobiology of Aging, 4 261–271.PubMedCrossRefGoogle Scholar
  46. Günther, W., Giunta, R., Klages, U., Haag, C., Steinberg, R., Satzger, W., Jonitz, L., & Engel, R. (1993). Findings of electroencephalographic brain mapping in mild to moderate dementia of the Alzheimer type during resting, motor, and music-perception conditions. Psychiatry Research: Neuroimaging, 50 163–176.PubMedCrossRefGoogle Scholar
  47. Gurland, B., Kuriansky, J., Sharpe, L., Simon, R., & Stiller, P. (1977). The comprehensive assessment and referral evaluation (CARE). International Journal of Aging and Human Development, 8 9–42.PubMedCrossRefGoogle Scholar
  48. Gustafson, L. (1992). Clinical classification of dementia conditions. Acta Neurologica Scandinav-ica, 139 16–20.CrossRefGoogle Scholar
  49. Herrmann, W., & Stephan, K. (1992). Moving from the question of efficacy to the question of therapeutic relevance: An exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. International Psychogeriatrics, 4 25–44.PubMedCrossRefGoogle Scholar
  50. Holttum, J., & Gershon, S. (1992). The cholinergic model of dementia, Alzheimer type: Progression from the unitary transmitter concept. Dementia, 3 174–185.Google Scholar
  51. Israel, J., Kozarevic, N., & Sarorius, N. (1984). Source book of geriatric assessment. Basel, Switzerland: Karger.Google Scholar
  52. Jacobson, R., Acker, C., & Lishman, W. (1990). Patterns of neuropsychological deficit in alcoholic Korsakoff’s syndrome. Psychological Medicines, 20 321–334.CrossRefGoogle Scholar
  53. Jarvik, L. F. (1992). Possible biological basis for a major memory disorder. In J. Morley, R. Coe, R. Strong, & G. Grossbergs (Eds.), Memory function and age related disorders. New York: Springer.Google Scholar
  54. Johnson, J. W., & Asher, P. (1987). Gylcine potentiates the NMDS response in cultured mouse brain neurons. Nature, 325 31–35.CrossRefGoogle Scholar
  55. Jones, H., Hedley-White, T., & Friedberg, S. (1985). Ataxic Creutzfeldt-Jakob disease: Diagnostic techniques and neuropathological observations in early disease. Neurology, 35 254–357.PubMedCrossRefGoogle Scholar
  56. Jung, R., & Solomon, K. (1993). Clinical practice and psychiatric manifestations of Pick’s disease. International Psychogeriatrics, 5 187–202.PubMedCrossRefGoogle Scholar
  57. Kay, D., Henderson, A., Scott, R., Wilson, J., Rickwood, D., & Grayson, D. (1985). Depression and dementia among the elderly living in the Hobart community. Psychological Medicine, 15 771–788.PubMedCrossRefGoogle Scholar
  58. Kraepelin, E. (1896). Psychiatrie: Ein Lehrbuch für Studierende und Aerzte. Leipzig, Germany: Verlag von Johann Ambrosius Bath.Google Scholar
  59. Kuhn, F. J., Schingnitz, G., Lehr, E., Montagna, E., Hansen, H. D., & Giachetti, A. (1988). Pharmacology of WEB-1881-F, a central cholinergic agent, which enhances cognition and cerebral metabolism. Archives of Internal Pharmacodynamic Therapy, 292 13–34.Google Scholar
  60. Kumar, A., Schapiro, M. B., Grady, C., Haxby, J. V., Wagner, E., Salerno, J. A., Friedland, R. P., & Rapoport, S. (1991). High-resolution PET studies in Alzheimer’s disease. Neuropsychophar-macology, 4 35–46.Google Scholar
  61. Kurz, A., Haupt, M., Pollmann, S., & Romero, B. (1992). Alzheimer’s disease: Is there evidence of phenomenological subtypes? Observations from a longitudinal study. Dementia, 3 320–327.Google Scholar
  62. Lamberty, G. J., & Bieliauskas, L. A. (1993). Distinguishing between depression and dementia in the elderly: A review of neuropsychological findings. Archives of Clinical Neuropsychology, 8 149–170.PubMedGoogle Scholar
  63. Levitt, A. J., & Karlinsky, H. (1992). Folate, vitamin B12, and cognitive impairment in patients with Alzheimer’s disease. Acta Psychiatrica Scandinavica, 86 301–305.PubMedCrossRefGoogle Scholar
  64. Marsden, C., & Fahn, S. (1987). Movement disorders II. London: Butterworths.Google Scholar
  65. Mendez, M., Selwood, A., Mastri, A., & Frey, W. (1993). Pick’s disease versus Alzheimer’s disease: A comparison of clinical characteristics. Neurology, 43 289–292.PubMedCrossRefGoogle Scholar
  66. Mielke, R., Herholz, K., Grond, M., Kessler, J., & Heiss, W. (1992). Severity of vascular dementia is related to volume of metabolically impaired tissue. Archives of Neurology, 49 909–913.PubMedCrossRefGoogle Scholar
  67. Miller, B., Cummings, J., Villanueva-Meyer, J., Boone, K., Mehringer, C., Lesser, I., & Mena, I. (1991). Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics. Neurology 41, 1374–1382.PubMedCrossRefGoogle Scholar
  68. Miyauchi, T., Hagimoto, H., Ishii, M., Endo, S., Tanaka, K., Kajiwara, S., Endo, M., Kajiwara, A., & Kosaka, K. (1994). Quantitative EEG in patients with presenile dementia of the Alzheimer type. Ada Neurologica Scandinavica, 89 56–64.CrossRefGoogle Scholar
  69. Mondadori, C., & Classen, W. (1984). Effect of oxiracetam on the performance of aged rates in a one way active avoidance situation. Clinical Neuropharmacology, 1984 770–771.Google Scholar
  70. Nissen, T., Mellgren, S., & Selseth, B. (1989). Démens evaluert med MMSE. Tidsskrift for den Norske Laegeforening, 109 1158–1162.PubMedGoogle Scholar
  71. Oberholzer, A., Hendriksen, C., Monsch, A., Hieierli, B., & Stahelin, H. (1992). Safety and effectiveness of low-dose clozapine in psychogeriatric patients: A preliminary study. International Psychogeriatrics, 4 187–195.PubMedCrossRefGoogle Scholar
  72. Ohno, M., Yamamoto, T., Kitajima, I., & Ueki, S. (1990). WEB 1881 F ameliorates impairment of working memory induced by scopolamine and cerebral ischemia in the three panel runway task. Japanese Journal of Pharmacology, 54 53–60.PubMedCrossRefGoogle Scholar
  73. Olafsson, K., Jorgensen, S., Jensen, H., Bille, A., Amp, P., & Andersen, J. (1992). Fluvoxamine in the treatment of demented patients: A double blind, placebo controlled study. Acta Psychiatrica Scandinavica, 85 453–456.PubMedCrossRefGoogle Scholar
  74. Onofri, M., Gambi, D., Del Re, M., Fulgente, T., Bazzano, S., Colamartino, P., & Malatesta, G. (1991). Mapping of event related potentials to auditory and visual odd ball paradigms in patients affected by different forms of dementia. European Neurology, 31 259–269.CrossRefGoogle Scholar
  75. Overall, J. E., & Schaltenbrand, R. (1992). The SKT neuropsychological test battery. Journal of Geriatric Psychiatry and Neurology, 5 220–227.PubMedGoogle Scholar
  76. Parsons, O., & Nixon, S. (1993). Neurobehavioral sequelae of alcoholism. Neurologic Clinics, 11 205–218.PubMedGoogle Scholar
  77. Pinner, E., & Rich, C. (1988). Effects of trazodone on aggressive behavior in seven patients with organic mental disorder. American Journal of Psychiatry, 145 1295–1296.PubMedGoogle Scholar
  78. Powell, A. L., Mezrich, R. S., Coyne, A. C., Loesberg, A., & Keller, I. (1993). Convex third ventricle: A possible sign for dementia using MRI. Journal of Geriatric Psychiatry and Neurology, 217-221.Google Scholar
  79. Rapp, M. S., Flint, A., Herrmann, N., & Proulx, G. (1992). Behavioral disturbances in the demented elderly: Phenomenology, pharmacotherapy, and behavioural management. Canadian Journal of Psychiatry, 37 651–657.Google Scholar
  80. Roman, G., Tatemichi, T., Erkinguntti, T., Cummings, J., Masdeu, J., Garcia, J., Amaducci, L., Orgogozo, J., Brun, A., Hofman, A., Moody, D., O’Brien, M., Yamaguchi, T., Grafman, J., Drayer, B., Bennet, D., Fisher, M., Ogata, J., Kokmen, E., Bermejo, E., Wolf, P., Gorelick, P., Bick, K., Pageau, A., Bell, M., DeCarli, C., Culebras, A., Korczyn, Z., Bogousslavsky, J., Hartmann, A., & Scheinberg, P. (1993). Vascular dementia: Diagnostic criteria for research studies. Neurology, 43 250–260.PubMedCrossRefGoogle Scholar
  81. Rosen, J., Mulsant, B., & Wright, B. (1992). Agitation in severely demented patients. Annals of Clinical Psychiatry, 4 207–215.CrossRefGoogle Scholar
  82. Roth, M., Tym, E., Mountjoy, C., Huppert, F., & Hendrie, H. (1986). CAMDE: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149 698–709.PubMedCrossRefGoogle Scholar
  83. Sabe, L., Jason, L., Juejati, M., Leiguarda, R., & Starkstein, S. (1993). Sensitivity and specificity of the mini-mental state exam in the diagnosis of dementia. Behavioural Neurology, 6 207–210.Google Scholar
  84. Saletu, B., & Anderer, P. (1988). EEG Mapping in der psychiatrischen diagnose und thera-pieforschung. In B. Saletu (Ed.), Biologische Psychiatrie. New York: Springer-Verlag.Google Scholar
  85. Saletu, B., Anderer, P., Fischhof, P., Lorenz, H., Barousch, R., & Bohmer, F. (1992). EEG mapping and psychopharmacological studies with deribufylline in SDAT and MID. Biological Psychiatry, 32 668–681.PubMedCrossRefGoogle Scholar
  86. Sawada, H., Udaka, F., Kameyama, M., Seriu, N., Nishinaka, K., Shindou, K., Kodama, M., Nishitani, N., & Okumiya, K. (1992). SPECT findings in Parkinson’s disease associated with dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 55 960–963.PubMedCrossRefGoogle Scholar
  87. Schneider, L., & Sobin, P. (1992). Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer’s disease and other dementias. Psychopharmacology Bulletin, 28 71–79.PubMedGoogle Scholar
  88. Schneider, L., Pollock, V., & Lyness, S. (1990). A metaanalysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatric Association, 38 553–563.Google Scholar
  89. Shorvon, S. D., Carney, M. W. P., Chanarin, I., & Reynolds, E. H. (1980). The neuropsychiatry of megaloblastic anaemia. British Journal of Medicine, 281 1036–1038.CrossRefGoogle Scholar
  90. Shulman, R. (1967). Vitamin B12 deficiency and psychiatric illness. British Journal of Psychiatry, 113 252–256.PubMedCrossRefGoogle Scholar
  91. Simpson, S., & Foster, D. (1986). Improvement in organically disturbed behavior with trazodone treatment. Journal of Clinical Psychiatry, 47 191–193.PubMedGoogle Scholar
  92. Skoog, I., Nilsson, L., Palmertz, B., Andreasson, L., & Svanborg, A. (1993). A population based study of dementia in 85 year olds. New England Journal of Medicine, 328 153–158.PubMedCrossRefGoogle Scholar
  93. Sneath, P., Chanarin, I., Hodkinson, H. M., McPherson, C. K., & Reynolds, E. H. (1973). Folate status in a geriatric population and its relation to dementia. Age and Aging, 2 177–182.CrossRefGoogle Scholar
  94. Spignoli, G., Pedata, F., Giovanelli, L., Banfi, S., Moroni, F., & Pepeu, G. (1986). Effect of oxiracetam and piracetam on central cholinergic mechanisms and active avoidance acquisition. Clinical Neuropharmacology, 9 S39–S47.PubMedGoogle Scholar
  95. Strathmann, G. C. (1988). Possible neurotransmitter basis of behavioral changes in Alzheimer’s disease. Annals of Neurology, 23 616–620.CrossRefGoogle Scholar
  96. Swaab, D. F. (1991). Brain aging and Alzheimer’s disease, “wear and tear” versus “use it or lose it.” Neurobiology of Aging, 12 317–324.PubMedCrossRefGoogle Scholar
  97. Urakami, K., Shimomura, T., Ohshima, T., Okada, A., Adachi, Y., Takahashi, K., Asakura, M., & Matsumura, R. (1993). Clinical effect of WEB 1881 (Nebracetam Fumurate) on patients with dementia of the Alzheimer type and study of its clinical pharmacology. Clinical Neuro-phamacology, 16 347–358.Google Scholar
  98. Van der Cammen, T., Van Harskamp, F., Stronks, D., Passchier, J., & Schudel, W. (1992). Value of the mini-mental status examination and informants’ data for the detection of dementia in geriatric outpatients. Psychological Reports, 71 1003–1009.PubMedGoogle Scholar
  99. Zappoli, R., Ametoli, G., Paganini, M., Battaglia, A., Novellini, R., & Pamparana, F. (1991). Topographic bit-mapped event-related neurocognitive potentials and clinical status in patients with primary presenile mental decline chronically treated with nicergoline. Current Therapeutic Research, 49 1078–1097.Google Scholar
  100. Zaudig, M. (1992). A new systematic method of measurement and diagnosis of “mild cognitive impairment” and dementia according to ICD-10 and DSM-III-R criteria. International Psy-chogeriatrics, 4 203–239.CrossRefGoogle Scholar
  101. Zaudig, M., Mittelhammer, J., Hiller, W., Pauls, A., & Thora, C. (1991). SIDAM-A structured interview for the diagnosis of dementia of the Alzheimer type multi-infarct dementia, and dementias of other etiology according to ICD-10 and DSM-III-R. Psychological Medicine, 21 225–236.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Charles J. Golden
    • 1
  • Antonia Chronopolous
    • 1
  1. 1.Center for Psychological StudiesNova Southeastern UniversityFort LauderdaleUSA

Personalised recommendations